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Editorial
Scientific Basis for the Incorporation of (Not So) 
New Devices by the Brazilian Public Health System
Áurea J. Chaves
I n Brazil, in several medical specialties, we often observe discrepancies between the Supplementary Health Care Network and the Unified Health System 
(Sistema Único de Saúde – SUS) regarding the offer 
of certified therapies for common diseases. In fact, 
over two-thirds of the population, who depend solely 
on the SUS, is deprived of the best that technology, 
can offer in healthcare. This is particularly true for 
the use of new devices in interventional cardiology. 
In pediatric cardiology, for instance, patent ductus 
arteriosus – one of the most common birth defects – 
has only coils approved for use by the SUS, which 
prevents percutaneous treatment for most patients. 
Among the many factors that hinder the adoption of 
new technologies by the SUS, economic factors pre-
dominate. In this sense, the search for robust scientific 
bases, which can help government agencies to make 
well-founded decisions, is very welcomed. Costa et al., 
from Hospital do Coração da Associação do Sanatório 
Sírio of São Paulo (SP), analyze the cost-effectiveness 
of percutaneous treatment vs. surgical treatment of 
patent ductus arteriosus from the perspective of SUS. 
Through stringent systematic review of the literature, 
the authors demonstrate the known safety and ef-
ficacy of the two techniques, as well as the lower 
morbidity and hospitalization time of percutaneous 
closure. The economic analysis showed that with a 
small reduction in the values of the prostheses, the 
percutaneous approach would attain an acceptable 
threshold for possible incorporation by SUS. Raul 
Rossi, Director of Interventions for Congenital Ab-
normalities of the Brazilian Society of Interventional 
Cardiology, in a corresponding editorial, recalls the 
growing gap that exists between the development of 
ever-better materials and their clinical use in Bra-
zil. He questions, and appropriately so, how long 
the population of Brazilian children should wait to 
have access to devices long-used in other countries, 
including those already available in our country for 
those who have access to supplementary health care. 
Finally, he welcomes the important work of Costa 
et al., which contributes to a scientifically rigorous 
theoretical foundation, which the Ministry of Health 
can use to make decisions about the incorporation 
of new devices.
Three articles in this issue address aspects related 
to the use of the transradial approach. Barbosa et al., 
from Irmandade da Santa Casa de Misericordia de 
Marília, Marília (SP), evaluate the incidence of radial 
artery occlusion at 24 hours and 30 days in patients 
with acute coronary syndrome submitted to invasive 
treatment, after the use of a selective compression 
device that aims to achieve hemostasis while maintain-
ing antegrade flow. Espírito Santo et al., from Instituto 
do Coração, Faculdade de Medicina, Universidade de 
São Paulo, São Paulo (SP), describe trends in the use 
of transradial access for more than a decade in that 
institution. They analyze, over time, the use of the 
transradial and transfemoral approaches for coronary 
procedures, in a tertiary institution that includes a 
clientele treated through SUS and Supplementary/
Private Health Care Network. Zukowski et al., from 
Santa Casa de Curitiba, Pontifícia Universidade Católica 
de Curitiba of Curitiba (PR), present the in-hospital 
outcomes of the transradial approach in an unselected 
population of patients older than 70 years submitted 
to percutaneous coronary intervention – a population 
that has a higher degree of atherosclerosis, calcifica-
tion, and vessel tortuosity.
In an unpublished article, Armaganijan et al., from 
Instituto de Cardiologia Dante Pazzanese, in São Paulo 
(SP), explore the effects of percutaneous renal sympa-
thetic denervation on renal artery diameter, as assessed 
by quantitative angiography. The increase in the diam-
eter of renal arteries, if appropriately confronted with 
other methods that evaluate sympathetic activity, such 
as microneurography and norepinephrine spillover, can 
be a practical tool, easy to implement and low-cost, 
which will assist in better understanding the results of 
percutaneous renal sympathetic denervation. 
In the endovascular area, Rodrigues et al., also 
from Instituto de Cardiologia Dante Pazzanese, evaluate 
outcomes at six months after using third-generation ultra-
flexible nitinol stents in the treatment of atherosclerotic 
lesions in popliteal artery segments. These are arterial 
segments near the knee joint, on which complex rota-
tional, tension, compression, and stretching forces act 
may influence middle- and long-term clinical outcomes.
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Finally, this issue brings other articles of great 
relevance, which evaluate questions, such as the im-
munohistochemical characteristics of coronary thrombi 
in diabetic patients with myocardial infarction with ST-
elevation, the results of primary coronary intervention 
according to the total time of ischemia, the performance 
of a titanium nitric oxide-coated stent in patients with 
multivessel coronary artery disease, and an algorithm 
for early removal of the femoral sheath.
Enjoy your reading!
Áurea J. Chaves 
Editor
